osaühing FAVOREK PEREARSTIKESKUS

Active Registry code 10813709 OÜ Tallinn Registered 13 Nov 2001

osaühing FAVOREK PEREARSTIKESKUS is a OÜ based in Tallinn, registry code 10813709, status: active. Main activity: General medical practice activities. Its annual report for 2025 shows revenue of €51 673 and 15 employees.

Turnover

—

State taxes

74 547 €

↑ 9.0% vs Q2 2026

Labour taxes

80 872 €

↑ 8.8% vs Q2 2026

Employees

−1 vs Q2 2026

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Human health activities · EMTAK 86

Labour taxes per employee 5 391 €

above 91% of companies

industry median 2 177 € · companies in the industry: 1 696
Revenue · 2025 51 673 €

above 65% of companies

industry median 20 811 € · companies in the industry: 3 373
Net profit margin · 2025 318.9 %

above 98% of companies

industry median 8.3 % · companies in the industry: 2 759

Taxes and turnover

Q4 2023 – Q3 2026

Labour taxes per employee, € Q3 2026: 5 391 € · +16.1% vs Q2 2026 · industry median 2 177 € · above 91% of the industry

Company
Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q3 2026: 15 · −6.3% vs Q2 2026

State taxes, € thousand Q3 2026: 74 547 € · +9.0% vs Q2 2026

Figures by quarter
Quarter	Turnover, €	State taxes, €	Labour taxes, €	Employees
Q3 2026	—	74 547	80 872	15
Q2 2026	—	68 367	74 320	16
Q1 2026	—	73 044	78 974	16
Q4 2025	—	73 135	78 503	16
Q3 2025	—	125 833	74 652	16
Q2 2025	—	66 376	71 169	16
Q1 2025	—	50 218	53 732	14
Q4 2024	—	76 463	68 129	14
Q3 2024	—	53 288	56 934	14
Q2 2024	—	61 158	65 245	14
Q1 2024	—	69 104	54 412	15
Q4 2023	—	55 602	59 582	15
Q3 2023	—	56 758	50 033	14
Q2 2023	—	60 138	46 597	14
Q1 2023	—	41 564	44 304	14
Q4 2022	—	50 830	43 923	14
Q3 2022	—	47 608	37 425	13
Q2 2022	—	57 428	53 780	14
Q1 2022	—	52 565	49 797	14

Labour taxes per employee per month

1 797 €

Q3 2026 · calculated from EMTA data

Financials by year

2016 – 2025

Revenue, € 2025: 51 673 € · +6.9% vs 2024 · industry median 20 811 € · above 65% of the industry

Company
Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € thousand 2025: 164 783 € · −43.9% vs 2024 · industry median 1 071 € · above 98% of the industry

Company
Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 318.9 % · −288.5 pp vs the year before · industry median 8.3 % · above 98% of the industry

Company
Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 558 207 € · −1.0% vs 2024

Equity, € thousand 2025: 434 611 € · −7.5% vs 2024

Employees 2025: 15 · +0.0% vs 2024 · industry median 2 · above 91% of the industry

Company
Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year	Revenue, €	Net profit, €	Labour costs, €	Assets, €	Equity, €	Employees
2025	51 673	164 783	683 107	558 207	434 611	15
2024	48 356	293 706	556 602	564 013	469 828	15
2023	45 208	251 672	463 920	438 632	348 029	15
2022	33 889	155 585	403 485	324 654	245 575	14
2021	43 987	184 050	402 423	327 150	263 634	15
2020	36 583	113 492	381 170	262 474	202 715	14
2019	62 910	118 495	320 832	223 985	181 223	13
2018	—	—	—	—	—	12
2017	—	—	—	—	—	14
2016	—	—	—	—	—	14
2015	—	—	—	—	—	12
2014	—	—	—	—	—	12
2013	—	—	—	—	—	12
2012	—	—	—	—	—	11
2011	—	—	—	—	—	11
2010	—	—	—	—	—	11
2009	—	—	—	—	—	7
2008	—	—	—	—	—	8
2007	—	—	—	—	—	8
2006	—	—	—	—	—	8
2005	—	—	—	—	—	7
2004	—	—	—	—	—	7
2002	—	—	—	—	—	6

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin

318.9 %

Net profit / revenue

Return on equity (ROE)

37.9 %

Net profit / equity

Return on assets (ROA)

29.5 %

Net profit / assets

Equity ratio

77.9 %

Equity / assets

Debt ratio

22.1 %

Liabilities / assets

Current ratio

4.86

Current assets / current liabilities

Revenue per employee

3 445 €

Revenue / average full-time employees

Labour cost per employee per month

3 795 €

Labour costs / employees / 12 months (incl. employer taxes)

Annual reports

PDFs from e-Äriregister

Annual reports
Year	Period	Filed	Report	Documents
2025	1 Jan 2025 – 31 Dec 2025	28 May 2026	Company’s own	e-Äriregister
2024	1 Jan 2024 – 31 Dec 2024	9 Jun 2025	Company’s own	e-Äriregister
2023	1 Jan 2023 – 31 Dec 2023	3 May 2024	Company’s own	e-Äriregister
2022	1 Jan 2022 – 31 Dec 2022	5 Mar 2023	Company’s own	e-Äriregister
2021	1 Jan 2021 – 31 Dec 2021	17 Mar 2022	Company’s own	e-Äriregister
2020	1 Jan 2020 – 31 Dec 2020	18 Mar 2021	Company’s own	e-Äriregister
2019	1 Jan 2019 – 31 Dec 2019	4 Mar 2020	Company’s own	e-Äriregister

Board

Anne Reiman
Board member · since 15 Feb 2016
Märt Rõngelep
Board member · since 18 Sep 2026

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Anne Reiman
Natural person · 1 417 €

52.48%
Anastasia Kudryashova
Natural person · 791 €

29.30%
Alla Rušai
Natural person · 442 €

16.37%
Helena Grauberg
Natural person · 50 €

1.85%

Beneficial owners

Anastasia Kudryashova
Direct ownership · since 31 Aug 2023
Anne Reiman
Direct ownership · since 17 Oct 2018

Founders and other persons

Osaühing WASP PROJECT
Founder · 40 000 € · 13 Nov 2001

shared board members, owners or beneficial owners

Activities (EMTAK)

86211General medical practice activities Main

Rulings 17

All rulings (PDF)

Rulings
Number, date	Title	Deadline	State	Document
Ä 10060403 / 16 18 Sep 2026	Amendment entry		In force 18 Sep 2026	PDF
Ä 10060403 / 15 12 Oct 2023	Amendment entry		In force 12 Oct 2023	PDF
Ä 10060403 / 14 1 Sep 2023	Amendment entry		In force 1 Sep 2023	PDF
Ä 10060403 / 13 12 Aug 2022	Amendment entry		In force 12 Aug 2022	PDF
Ä 10060403 / 12 4 Apr 2022	Amendment entry		In force 4 Apr 2022	PDF
Ä 10060403 / M4 15 Mar 2022	Procedural ruling	14 Apr 2022	Deficiencies eliminated 17 Mar 2022	PDF
Ä 10060403 / 11 29 Sep 2020	Amendment entry		In force 29 Sep 2020	PDF
Ä 10060403 / 10 17 Jan 2018	Amendment entry		In force 17 Jan 2018	PDF
Ä 10060403 / 9 8 Nov 2017	Amendment entry		In force 8 Nov 2017	PDF
Ä 10060403 / 8 15 Feb 2016	Amendment entry		In force 15 Feb 2016	PDF
Ä 10060403 / 7 9 Nov 2015	Amendment under Commercial Code § 525 (2)		In force 9 Nov 2015	PDF
Ä 10060403 / 6 30 Sep 2011	Amendment entry		In force 30 Sep 2011	PDF
Ä 10060403 / M3 23 Sep 2011	Ruling to eliminate deficiencies	31 Oct 2011	In force 23 Sep 2011	PDF
Ä 10060403 / M2 16 Sep 2011	Ruling to eliminate deficiencies	17 Oct 2011	In force 16 Sep 2011	PDF
Ä 60403 / 5 3 Dec 2008	Deletion of activities from the registry card		In force 3 Dec 2008	PDF
Ä 60403 / 4 20 Feb 2006	Amendment entry		In force 20 Feb 2006	PDF
Ä 60403 / 3 16 Apr 2002	Unpublished amendment entry		In force	PDF

Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data

osaühing FAVOREK PEREARSTIKESKUS

Position in the industry Human health activities · EMTAK 86

Taxes and turnover

Financials by year

Financial ratios for 2025

Annual reports

Board

Right of representation

Owners

Beneficial owners

Founders and other persons

Related companies

Activities (EMTAK)

Rulings 17